2015
DOI: 10.1016/j.bios.2015.05.069
|View full text |Cite
|
Sign up to set email alerts
|

G-quadruplex DNAzyme-based electrochemiluminescence biosensing strategy for VEGF165 detection: Combination of aptamer–target recognition and T7 exonuclease-assisted cycling signal amplification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(18 citation statements)
references
References 45 publications
(63 reference statements)
0
18
0
Order By: Relevance
“…ECL decrement (Δ I = I 0 – I , where I 0 is the maximum ECL intensity of GCE-ABA-S1-aptamer-CIS/ZnS and I is the maximum ECL intensity of GCE-ABA-S1-aptamer-CIS/ZnS-VEGF 165 ) increased linearly with the logarithmically increasing concentration of VEGF 165 in a range from 0.10 to 1000 pM (inset, Figure , R = 0.99) with a limit of detection of 0.050 pM (S/N = 3). GCE-ABA-S1-aptamer-CIS/ZnS-VEGF 165 not only displayed comparable or even better sensitivity than previously reported VEGF 165 determining strategies (Tables S2) , but also demonstrated acceptable selectivity to common interfering substances such as BSA, ascorbic acid, and thrombin (Figure S4). The desired selectivity of the proposed ECL sensor for VEGF 165 was derived from the bioselective reaction between DNA capture probe S1, VEGF 165 aptamer, and VEGF 165 …”
Section: Resultsmentioning
confidence: 60%
See 2 more Smart Citations
“…ECL decrement (Δ I = I 0 – I , where I 0 is the maximum ECL intensity of GCE-ABA-S1-aptamer-CIS/ZnS and I is the maximum ECL intensity of GCE-ABA-S1-aptamer-CIS/ZnS-VEGF 165 ) increased linearly with the logarithmically increasing concentration of VEGF 165 in a range from 0.10 to 1000 pM (inset, Figure , R = 0.99) with a limit of detection of 0.050 pM (S/N = 3). GCE-ABA-S1-aptamer-CIS/ZnS-VEGF 165 not only displayed comparable or even better sensitivity than previously reported VEGF 165 determining strategies (Tables S2) , but also demonstrated acceptable selectivity to common interfering substances such as BSA, ascorbic acid, and thrombin (Figure S4). The desired selectivity of the proposed ECL sensor for VEGF 165 was derived from the bioselective reaction between DNA capture probe S1, VEGF 165 aptamer, and VEGF 165 …”
Section: Resultsmentioning
confidence: 60%
“…HPLC-purified DNA capture probe S1, VEGF 165 aptamer, and VEGF 165 were purchased from Shanghai Sangon Biological Engineering Technology and Services Co. Ltd. (Shanghai, China). VEGF 165 aptamer was modified with a carboxyl group at the 5′-terminus and its sequence is as follows: 5′-COOH-GGCCCGTCCGTATGGTGGGTGTGCTGGCC-3′ . DNA capture probe S1 was modified at the 5′-terminus with an amino group and its sequence is as follows: 5′-NH 2 -TTTTTTTATGGGTTGGGCGGGATGGGCCAGCACACCCACC-3′ .…”
Section: Experimental Sectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Using systematic evolution of ligands by exponential enrichment (SELEX) strategies, a variety of VEGF 165 and CEA aptamers have been identified by previous studies. [36][37][38] Referring to the existing studies of VEGF 165 and CEA aptamers, the aptamer sequences designed in this study are shown in Table 1. [39][40][41][42] The VEGF 165 and CEA aptamers have been proved to bind to their corresponding targets with high affinity, respectively.…”
Section: Introductionmentioning
confidence: 99%
“… 19 Therefore, they are regarded as an alternative to antibody-based methods. Up to now, a variety of aptamer-based analytical strategies for the detection of VEGF 165 have been reported, such as differential pulse voltammetry (DPV), 20,21 electrochemical impedance spectroscopy (EIS), 11 photoelectrochemical (PEC), 22 electrochemiluminescence (ECL), 23 chemiluminescence (CL), 24,25 and time-resolved fluorescence (TR-FL). 26 These methods have good specificity and stability compared to traditional approaches.…”
Section: Introductionmentioning
confidence: 99%